| 查看: 136 | 回复: 1 | |||
| 当前主题已经存档。 | |||
[交流]
信不信由你-吸烟也治病
|
|||
|
最近,美国加州的科学家发现,烟碱中的代谢物:去甲烟碱对于A beta蛋白的糖基化,会抑制A beta导致的阿尔氏海默病(老年痴呆症)。原理是去甲烟碱会共价性的改变糖化A beta的构象。此文一出,可谓在amyloid研究领域激起千层浪 文章摘要如下 Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease The origin of Alzheimer's disease (AD) has been subjected to an intense amount of examination; however, a clear conclusion as to the nature of this crippling disease has yet to be identified. What is readily accepted is that a definitive marker of this disease is the aggregation of the amyloid beta-peptide (A beta) into neuritic plaques. The recent observation that nicotine exposure leads to delayed onset of AD has stimulated a flurry of research into the nature of this neuroprotective effect. This phenomenon has been debated, but no consensus has been reached, and although these studies have targeted nicotine, the primary alkaloid in tobacco, few studies have considered the physiological role of nicotine metabolites in disease states. Nornicotine is a major nicotine metabolite in the CNS and has been shown to participate in the aberrant glycation of proteins in vivo in a process termed nornicotine-based glycation. Herein is detailed a potentially fortuitous role of nornicotine-based glycation in relation to the pathology of AD. Specifically, nornicotine was found to covalently alter A beta, leading to reduced peptide aggregation. Potential consequences of this reaction cascade include reduced plaque formation and/or altered clearance of the peptide, as well as attenuated toxicity of soluble A beta aggregates. The findings described provide an alternative mechanism for nicotine neuroprotection in AD and a means for the alteration of amyloid folding based on a covalent chemical event |
» 猜你喜欢
中医311求调剂
已经有0人回复
预测2023年广东省企联合基金项目公布时间
已经有15人回复
微生物学论文润色/翻译怎么收费?
已经有176人回复
转投出现ADM:not assigned 一个月
已经有0人回复
转投一个月后一直停留在ADM:not assigned
已经有0人回复
求调剂
已经有0人回复
杭州师范大学基础医学院免疫与病原生物学系-刘广宇课题组
已经有0人回复
杭州师范大学基础医学院研究生调剂招生火热来袭
已经有0人回复
0860生物医药/1053公共卫生-厦门大学少干计划专硕调剂;另有非全日制公卫专硕名额调剂
已经有0人回复
厦门大学国家重点实验室病原微生物与抗感染治疗课题组2026届博士招生
已经有0人回复
医学类期刊求推荐
已经有8人回复
2楼2006-03-20 09:11:50










回复此楼
100